NEW YORK (AP) — The U.S. subsidiaries of French pharmaceutical giant Sanofi will pay $109 million to settle allegations they gave kickbacks to induce doctors to buy and prescribe Hyalgan, a knee injection.
The Justice Department alleges that Sanofi-Aventis U.S. Inc. and Sanofi-Aventis U.S. LLC violated the False Claims Act by giving doctors thousands of free units of Hyalgan as the drug faced pressure from a lower-priced competitor.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.